Location: New York, NY
CIK: 0001493215 · Show all filings
Period: Q2 2024 (← Previous) (Next →)
Filing Date: Aug 14, 2024
Total Value: $6.459B (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| MDGL | MADRIGAL PHARMACEUTICALS INC | 1,915,862 | $537M | 8.3% | $230.67 | +3.2% | COM | 558868105 |
| RCKT | ROCKET PHARMACEUTICALS INC | 17,687,772 | $381M | 5.9% | $17.75 | +29.4% | COM | 77313F106 |
| AXSM | AXSOME THERAPEUTICS INC | 4,634,331 | $373M | 5.8% | $56.00 | +32.2% | COM | 05464T104 |
| RNAM | AVIDITY BIOSCIENCES INC | 8,806,838 | $360M | 5.6% | $23.99 | +19.6% | COM | 05370A108 |
| ARGX | ARGENX SE | 654,430 | $281M | 4.4% | $344.30 | — | SPONSORED ADR | 04016X101 |
| NTRA | NATERA INC | 2,593,323 | $281M | 4.3% | $42.76 | +137.5% | COM | 632307104 |
| — | MERUS N V | 4,169,393 | $247M | 3.8% | $34.07 | — | COM | N5749R100 |
| INSM | INSMED INC | 3,640,108 | $244M | 3.8% | $29.56 | +31.2% | COM PAR $.01 | 457669307 |
| PTCT | PTC THERAPEUTICS INC | 7,393,127 | $226M | 3.5% | $38.04 | -14.8% | COM | 69366J200 |
| DYN | DYNE THERAPEUTICS INC | 6,387,138 | $225M | 3.5% | $25.94 | +12.0% | COM | 26818M108 |
| ACAD | ACADIA PHARMACEUTICALS INC | 13,707,506 | $223M | 3.4% | $21.38 | -24.5% | COM | 004225108 |
| BRKR | BRUKER CORP | 3,444,095 | $220M | 3.4% | $73.00 | +2.4% | COM | 116794108 |
| MASI | MASIMO CORP | 1,462,400 | $184M | 2.9% | $166.52 | -20.9% | COM | 574795100 |
| PTGX | PROTAGONIST THERAPEUTICS INC | 5,286,404 | $183M | 2.8% | $21.97 | +33.3% | COM | 74366E102 |
| ALKS | ALKERMES PLC | 7,056,988 | $170M | 2.6% | $26.93 | -8.9% | SHS | G01767105 |
| IMCR | IMMUNOCORE HLDGS PLC | 4,869,798 | $165M | 2.6% | $43.23 | — | ADS | 45258D105 |
| CYTK | CYTOKINETICS INC | 2,721,158 | $147M | 2.3% | $29.14 | +107.1% | COM NEW | 23282W605 |
| RARE | ULTRAGENYX PHARMACEUTICAL IN | 3,259,927 | $134M | 2.1% | $50.54 | -15.5% | COM | 90400D108 |
| PEN | PENUMBRA INC | 742,105 | $134M | 2.1% | $253.65 | -21.3% | COM | 70975L107 |
| — | AKERO THERAPEUTICS INC | 5,431,985 | $127M | 2.0% | $24.00 | — | COM | 00973Y108 |
| ESTA | ESTABLISHMENT LABS HLDGS INC | 2,675,703 | $122M | 1.9% | $28.18 | +80.0% | COM | G31249108 |
| IMTX | IMMATICS N.V | 10,000,000 | $116M | 1.8% | $11.40 | -1.2% | SHS | N44445109 |
| RDNT | RADNET INC | 1,856,010 | $109M | 1.7% | $38.35 | +41.5% | COM | 750491102 |
| APGE | APOGEE THERAPEUTICS INC | 2,712,096 | $107M | 1.7% | $27.01 | +79.7% | COM | 03770N101 |
| TARS | TARSUS PHARMACEUTICALS INC | 3,412,486 | $92.75M | 1.4% | $24.90 | +35.0% | COM | 87650L103 |
| ISRG | INTUITIVE SURGICAL INC | 202,456 | $90.06M | 1.4% | $388.30 | +2.6% | COM NEW | 46120E602 |
| ARVN | ARVINAS INC | 2,967,897 | $79.01M | 1.2% | $23.38 | +36.3% | COM | 04335A105 |
| SYRE | SPYRE THERAPEUTICS INC | 3,258,360 | $76.6M | 1.2% | $20.06 | +68.2% | COM NEW | 00773J202 |
| — | CARGO THERAPEUTICS INC | 4,078,122 | $66.96M | 1.0% | $22.58 | — | COM | 14179K101 |
| URGN | UROGEN PHARMA LTD | 3,557,347 | $59.69M | 0.9% | $15.23 | -6.6% | COM | M96088105 |
| — | SAGE THERAPEUTICS INC | 5,480,577 | $59.52M | 0.9% | $20.48 | — | COM | 78667J108 |
| — | 89BIO INC | 7,378,548 | $59.1M | 0.9% | $11.28 | — | COM | 282559103 |
| STOK | STOKE THERAPEUTICS INC | 4,224,838 | $57.08M | 0.9% | $24.12 | -44.0% | COM | 86150R107 |
| OBIO | ORCHESTRA BIOMED HLDGS INC | 5,620,640 | $45.81M | 0.7% | $11.90 | -51.3% | COM | 68572M106 |
| GKOS | GLAUKOS CORP | 386,291 | $45.72M | 0.7% | $103.61 | +2.5% | COM | 377322102 |
| CGON | CG ONCOLOGY INC | 1,344,074 | $42.43M | 0.7% | $36.56 | -5.2% | COM | 156944100 |
| TSHA | TAYSHA GENE THERAPIES INC | 18,800,299 | $42.11M | 0.7% | $1.90 | +53.2% | COM SHS | 877619106 |
| NGNE | NEUROGENE INC | 1,070,565 | $38.96M | 0.6% | $33.93 | +4.0% | COM | 64135M105 |
| GHRS | GH RESEARCH PLC | 3,327,129 | $38.79M | 0.6% | $17.34 | -30.8% | ORDINARY SHARES | G3855L106 |
| VCEL | VERICEL CORP | 801,397 | $36.77M | 0.6% | $13.91 | +239.1% | COM | 92346J108 |
| FULC | FULCRUM THERAPEUTICS INC | 5,845,956 | $36.24M | 0.6% | $10.45 | -27.5% | COM | 359616109 |
| CGEM | CULLINAN THERAPEUTICS INC | 1,052,630 | $18.36M | 0.3% | $21.29 | 0.0% | COM | 230031106 |
| DNTH | DIANTHUS THERAPEUTICS INC | 666,667 | $17.25M | 0.3% | $21.73 | +10.6% | COM | 252828108 |
| ROIV | ROIVANT SCIENCES LTD | 1,454,273 | $15.37M | 0.2% | $8.28 | +32.4% | SHS | G76279101 |
| LENZ | LENZ THERAPEUTICS INC | 863,389 | $14.93M | 0.2% | $20.79 | -16.0% | COM | 52635N103 |
| TEM | TEMPUS AI INC | 400,000 | $14M | 0.2% | $30.66 | 0.0% | CL A | 88023B103 |
| KYTX | KYVERNA THERAPEUTICS INC | 1,852,711 | $13.9M | 0.2% | $27.84 | -45.1% | COM | 501976104 |
| — | ESSA PHARMA INC | 2,298,662 | $12.09M | 0.2% | $6.60 | — | COM NEW | 29668H708 |
| REPL | REPLIMUNE GROUP INC | 1,133,787 | $10.2M | 0.2% | $6.97 | 0.0% | COM | 76029N106 |
| TXG | 10X GENOMICS INC | 502,856 | $9.781M | 0.2% | $60.97 | -57.1% | CL A COM | 88025U109 |
| — | TOURMALINE BIO INC | 741,656 | $9.538M | 0.1% | $24.66 | — | COM | 89157D105 |
| VRDN | VIRIDIAN THERAPEUTICS INC | 605,816 | $7.882M | 0.1% | $15.79 | -12.3% | COM | 92790C104 |
| PCSC | PERCEPTIVE CAP SOLUTIONS COR | 742,500 | $7.47M | 0.1% | $10.07 | 0.0% | CL A ORD SHS | G70077105 |
| — | ARCA BIOPHARMA INC | 1,400,000 | $5.362M | 0.1% | $3.83 | — | COM | 00211Y506 |
| IMUX | IMMUNIC INC | 4,567,717 | $5.07M | 0.1% | $8.52 | -85.4% | COM | 4525EP101 |
| GPCR | STRUCTURE THERAPEUTICS INC | 125,000 | $4.909M | 0.1% | $39.27 | — | SPONSORED ADS | 86366E106 |
| — | ACELYRIN INC | 978,310 | $4.314M | 0.1% | $20.90 | — | COM | 00445A100 |
| MIST | MILESTONE PHARMACEUTICALS IN | 3,256,102 | $4.298M | 0.1% | $20.06 | -92.0% | COM | 59935V107 |
| RGNX | REGENXBIO INC | 350,000 | $4.095M | 0.1% | $17.79 | -12.5% | COM | 75901B107 |
| — | ALLURION TECHNOLOGIES INC | 3,697,549 | $3.689M | 0.1% | $4.09 | — | COM SHS | 02008G102 |
| XGN | EXAGEN INC | 1,511,866 | $2.752M | 0.0% | $11.83 | -85.7% | COM | 30068X103 |
| SABS | SAB BIOTHERAPEUTICS INC | 766,946 | $2.378M | 0.0% | $5.51 | -33.4% | COM NEW | 78397T202 |
| — | CUTERA INC | 1,331,776 | $2.011M | 0.0% | $46.88 | — | COM | 232109108 |
| SGMT | SAGIMET BIOSCIENCES INC | 500,000 | $1.71M | 0.0% | $7.18 | -36.1% | COM SER A | 786700104 |
| — | ARYA SCIENCES ACQU CORP IV | 127,970 | $1.468M | 0.0% | $10.47 | — | CL A | G31659108 |
| CTMX | CYTOMX THERAPEUTICS INC | 1,200,002 | $1.464M | 0.0% | $1.99 | 0.0% | COM | 23284F105 |
| — | ADICET BIO INC | 1,053,688 | $1.275M | 0.0% | $16.61 | — | COM | 007002108 |
| RCKTW | ROCKET PHARMACEUTICALS INC | 350,000 | $21,245 | 0.0% | $0.11 | — | *W EXP 09/02/202 | 77313F114 |